Experts envision a valuable role for tau‐PET in clinical practice and drug trials
Marie R. Vermeiren, Ismael Luis Calandri, Wiesje M. van der Flier, Elsmarieke van de Giessen, Rik Ossenkoppele · 2025
Read Experts envision a valuable role for tau‐PET in clinical practice and drug trials by Marie R. Vermeiren, Ismael Luis Calandri, Wiesje M. van der Flier, Elsmarieke van de Giessen, Rik Ossenkoppele (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714265.txt.
Description
Marie Vermeiren, Ismael Luis Calandri, Wiesje van der Flier, Elsmarieke van de Giessen, and Rik Ossenkoppele surveyed experts on tau-PET brain scans in 2025. New Alzheimer's biomarkers and drug trials raise the question of where tau imaging fits in care and research. The team asked dementia and imaging experts worldwide.
In total, two hundred sixty-nine experts from six continents answered. Ninety percent saw added value for tau-PET in practice, above all for staging, diagnosis, monitoring, and outlook in memory clinic patients. Case vignettes showed the scan judged most useful in certain diagnostic puzzles. Opinions on its role in drug trials were also gathered. The authors report a field broadly ready to use the scan.
Catalog record
| CREATOR | Marie R. Vermeiren, Ismael Luis Calandri, Wiesje M. van der Flier, Elsmarieke van de Giessen, Rik Ossenkoppele |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |